Tag: Biopharmaceutical

Browse exclusive Tags!

Telix Pharmaceuticals Plans $200M IPO in the US, Nasdaq Listing imminent, Australia

Telix Pharmaceuticals plans $200M IPO on Nasdaq. Explore market potential with InvestingPro for informed investment decisions. #TLX #IPO #Biopharma.

Paratek Pharmaceuticals to Unveil Groundbreaking Research at IDWeek 2023, US

Paratek Pharmaceuticals presents groundbreaking research at IDWeek 2023, featuring new data from NUZYRA programs. Learn more on their website.

Major Acquisition: Biopharmaceutical Giant Acquires Two Companies for Obesity & Diabetes Treatments

Biopharmaceutical giant completes major acquisition, revolutionizing obesity and diabetes treatments. Learn more about their innovative solutions.

Aurinia Pharma’s potential takeover could push shares to high $20s to low $30s, predicts analyst

Get insights on takeover speculations and potential value of Canadian biopharmaceutical company Aurinia Pharma in the market. Analysts' estimations and investor interest. Read more.

Popular

Budapest’s Turbine secures €5.5M for cancer therapy research using cell simulation and machine learning

Budapest-based biopharmaceutical company Turbine raises €5.5m in funding round from MassMutual Ventures. This will support development of simulation-guided drug therapies uncovering new cancer therapies through cell simulation and machine learning.

Paratek Pharmaceuticals to Unveil Groundbreaking Research at IDWeek 2023, US

Paratek Pharmaceuticals presents groundbreaking research at IDWeek 2023, featuring new data from NUZYRA programs. Learn more on their website.

Aurinia Pharma’s potential takeover could push shares to high $20s to low $30s, predicts analyst

Get insights on takeover speculations and potential value of Canadian biopharmaceutical company Aurinia Pharma in the market. Analysts' estimations and investor interest. Read more.

Bhavana Agrawal to assume role of Chief Financial Officer at AstraZeneca India in October

AstraZeneca India appoints Bhavana Agrawal as new CFO, succeeding Rajesh Marwaha, who will retire. Agrawal brings two decades of expertise to the role.

Subscribe

spot_imgspot_img